Survey of current prenatal screening for Down syndrome in Australian hospitals providing maternity care

被引:6
|
作者
Lawrence, K [1 ]
Crowther, CA [1 ]
机构
[1] Univ Adelaide, Dept Obstet & Gynaecol, Womens & Childrens Hosp, Adelaide, SA 5001, Australia
关键词
Down syndrome; maternal serum screening; nuchal translucency screening; screening tests;
D O I
10.1046/j.0004-8666.2003.00071.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The present study assessed the screening tests for Down syndrome available to women within Australian hospitals. Methods: Postal questionnaires. Results: A total of 282 (57%) hospitals responded with over two-thirds offering some form of screening test which varied by geographical region and level of institution. First trimester maternal serum screening was offered by 11% of hospitals. Nuchal translucency screening was offered by 52% of hospitals with higher use in Australian Capital Territory and New South Wales than in the other regions. Second trimester maternal serum screening was offered by 75% of hospitals with higher rates in Australian Capital Territory, South Australia and the lowest rate in Queensland. Conclusions: A high proportion of women are offered screening but with wide variation in the tests used.
引用
收藏
页码:222 / 225
页数:4
相关论文
共 50 条
  • [31] Clinical application of inhibin A measurement: Prenatal serum screening for Down syndrome
    Lambert-Messerlian, GM
    Canick, JA
    SEMINARS IN REPRODUCTIVE MEDICINE, 2004, 22 (03) : 235 - 242
  • [32] ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome
    Wang, Min
    Lu, Shiming
    Zhu, Yuning
    Li, Hui
    PRENATAL DIAGNOSIS, 2010, 30 (06) : 561 - 564
  • [33] Information about prenatal screening for Down syndrome Ethnic differences in knowledge
    Fransen, Mirjam P.
    Wildschut, Hajo
    Vogel, Ineke
    Mackenbach, Johan
    Steegers, Eric
    Essink-Bot, Marie-Louise
    PATIENT EDUCATION AND COUNSELING, 2009, 77 (02) : 279 - 288
  • [34] Cross-trimester marker ratios in prenatal screening for Down syndrome
    Wald, Nicholas J.
    Bestwick, Jonathan P.
    Morris, Joan K.
    PRENATAL DIAGNOSIS, 2006, 26 (06) : 514 - 523
  • [35] Prenatal screening for Down syndrome and neural tube defects in twin pregnancies
    Wald, NJ
    Rish, S
    PRENATAL DIAGNOSIS, 2005, 25 (09) : 740 - 745
  • [36] A qualitative investigation of the decision-making process of couples considering prenatal screening for Down syndrome
    Carroll, Fran E.
    Owen-Smith, Amanda
    Shaw, Alison
    Montgomery, Alan A.
    PRENATAL DIAGNOSIS, 2012, 32 (01) : 57 - 63
  • [37] Noninvasive prenatal diagnosis of Down syndrome: current knowledge and novel insights
    Sifakis, Stavros
    Papantoniou, Nikos
    Kappou, Dimitra
    Antsaklis, Aris
    JOURNAL OF PERINATAL MEDICINE, 2012, 40 (04) : 319 - 327
  • [38] Prenatal screening for Down syndrome: women's involvement in decision-making and their attitudes to screening
    Seror, Valerie
    Ville, Yves
    PRENATAL DIAGNOSIS, 2009, 29 (02) : 120 - 128
  • [39] Survey of attitudes of pregnant women towards Down syndrome screening
    Al-Jader, LN
    Parry-Langdon, N
    Smith, RJW
    PRENATAL DIAGNOSIS, 2000, 20 (01) : 23 - 29
  • [40] Costs and effects of prenatal screening methods for Down syndrome and neural tube defects
    Hoogendoorn, Mirjam
    Evers, Silvia M. A. A.
    Schielen, Peter C. J. I.
    van Genugten, Marianne L. L.
    de Wit, G. Ardine
    Ament, Andre J. H. A.
    COMMUNITY GENETICS, 2008, 11 (06) : 359 - 367